MORGAN STANLEY PLC/CALL/MEDTRONIC/112.5/0.1/20.12.24 Share Price

Warrant

DE000MB98UE2

Market Closed - Börse Stuttgart 17:49:26 31/05/2024 BST
0.031 EUR +6.90% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/112.5/0.1/20.12.24
Current month-11.43%
1 month-11.43%
Date Price Change
31/05/24 0.031 +6.90%
30/05/24 0.029 -3.33%
29/05/24 0.03 -.--%
28/05/24 0.03 -.--%
27/05/24 0.03 -6.25%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 05:49 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB98UE
ISINDE000MB98UE2
Date issued 28/07/2023
Strike 112.5 $
Maturity 20/12/2024 (202 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.31
Lowest since issue 0.024
Spread 0.008
Spread %20.00%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.37 USD
Average target price
94.07 USD
Spread / Average Target
+15.61%
Consensus